Summary.
We investigated serum ghrelin levels (SGL) in 12 patients with schizophrenia over a 10-week period after initiation of clozapine treatment. In contrast to increments of body mass indices (BMI, kg/m2) and serum leptin levels (SLL), no significant change in SGL was detected. Inverse correlations between delta SGL and delta SLL did not reach statistical significance. Linear mixed model analysis could not detect effects of age, sex, BMI, SLL and serum clozapine levels on SGL. Our results do not support a causal involvement of ghrelin in clozapine-related weight gain.
Similar content being viewed by others
References
DB Allison JL Mentore M Heo LP Chandler JC Cappelleri MC Infante PJ Weiden (1999) ArticleTitleAntipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 156 1686–1696 Occurrence Handle10553730
M Atmaca M Kuloglu E Tezcan B Ustundag (2003) ArticleTitleSerum leptin and triglyceride levels in patients on treatment with atypical antipsychotics. J Clin Psychiatry 64 598–604 Occurrence Handle12755665
T Baptista A Lacruz S de Mendoza JM Mendoza Guillen R Silvera F Angeles MT Mendoza L Hernandez (2000) ArticleTitleBody weight gain after administration of antipsychotic drugs: correlation with leptin, insulin and reproductive hormones. Pharmacopsychiatry 33 81–88 Occurrence Handle10.1055/s-2000-8451 Occurrence Handle10855458
T Brömel WF Blum A Ziegler E Schulz M Bender C Fleischhaker H Remschmidt JC Krieg J Hebebrand (1998) ArticleTitleSerum leptin levels increase rapidly after initiation of clozapine therapy. Mol Psychiatry 3 76–80 Occurrence Handle10.1038/sj.mp.4000352 Occurrence Handle9491817
Brown H, Prescott R (1999) Applied mixed models in medicine. John Wiley & Sons, Chichester New York Weinheim Brisbane Singapore Toronto
JM Friedman JL Halaas (1998) ArticleTitleLeptin and the regulation of body weight in mammals. Nature 395 763–770 Occurrence Handle10.1038/27376 Occurrence Handle9796811
D Gothelf B Falk P Singer M Kairi M Phillip L Zigel I Poraz S Frishman N Constantini G Zalsman A Weizman A Apter (2002) ArticleTitleWeight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine. Am J Psychiatry 159 1055–1057 Occurrence Handle10.1176/appi.ajp.159.6.1055 Occurrence Handle12042200
T Kraus M Haack A Schuld D Hinze-Selch M Kuhn M Uhr T Pollmächer (1999) ArticleTitleBody weight and leptin plasma levels during treatment with antipsychotic drugs. Am J Psychiatry 156 312–314 Occurrence Handle9989571
R Leadbetter M Shutty D Pavalonis V Vieweg P Higgins M Downs (1992) ArticleTitleClozapine-induced weight gain: prevalence and clinical relevance. Am J Psychiatry 149 68–72 Occurrence Handle1728188
M Nakazato N Murakami Y Date M Kojima H Matsuo K Kangawa S Matsukura (2001) ArticleTitleA role for ghrelin in the central regulation of feeding. Nature 409 194–198 Occurrence Handle10.1038/35051587 Occurrence Handle11196643
B Otto U Cuntz E Fruehauf R Wawarta C Folwaczny RL Riepl ML Heiman P Lehnert M Fichter M Tschöp (2001) ArticleTitleWeight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur J Endocrinol 145 669–673 Occurrence Handle10.1530/eje.0.1450669
E Schulz C Fleischhaker H Remschmidt (1995) ArticleTitleDetermination of clozapine and its major metabolites in serum samples of adolescent schizophrenic patients by high-performance liquid chromatography – data from a prospective clinical trial. Pharmacopsychiatry 28 20–25 Occurrence Handle7746841
FM Theisen S Cichon A Linden M Martin H Remschmidt J Hebebrand (2001) ArticleTitleClozapine and weight gain. Am J Psychiatry 158 816 Occurrence Handle10.1176/appi.ajp.158.5.816
FM Theisen A Linden IR König M Martin H Remschmidt J Hebebrand (2003) ArticleTitleSpectrum of binge eating symptomatology in patients treated with clozapine and olanzapine. J Neural Transm 110 111–121 Occurrence Handle12541016
T Togo K Hasegawa S Miura H Hosojima K Kojima M Shoji A Kase H Uchikado E Iseki K Kosaka (2004) ArticleTitleSerum ghrelin concentrations in patients receiving olanzapine or risperidone. Psychopharmacology 172 230–232 Occurrence Handle10.1007/s00213-003-1642-4 Occurrence Handle14551671
M Tschöp DL Smiley ML Heiman (2000) ArticleTitleGhrelin induces adiposity in rodents. Nature 407 908–913
M Tschöp C Weyer AP Tataranni V Devanarayan E Ravussin ML Heiman (2001) ArticleTitleCirculating ghrelin levels are decreased in human obesity. Diabetes 50 707–709 Occurrence Handle11289032
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Theisen, F., Gebhardt, S., Brömel, T. et al. A prospective study of serum ghrelin levels in patients treated with clozapine. J Neural Transm 112, 1411–1416 (2005). https://doi.org/10.1007/s00702-005-0284-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-005-0284-6